Combination of recombinant human endostatin and TACE in treatment of primary hepatic cancer and parameter changes of CT perfusion[J]. Journal of Clinical Medicine in Practice, 2014, (23): 73-76. DOI: 10.7619/jcmp.201423024
Citation: Combination of recombinant human endostatin and TACE in treatment of primary hepatic cancer and parameter changes of CT perfusion[J]. Journal of Clinical Medicine in Practice, 2014, (23): 73-76. DOI: 10.7619/jcmp.201423024

Combination of recombinant human endostatin and TACE in treatment of primary hepatic cancer and parameter changes of CT perfusion

  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return